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Abstract
Introduction Transanal advancement flap repair (TAFR)
provides a useful tool in the treatment of high trans-
sphincteric fistulas. Recent studies indicate that TAFR fails
in one out of three patients. Until now, no definite
predictive factor for failure has been identified. Although
some authors have reported that preoperative seton drainage
might improve the outcome of TAFR, this could not be
confirmed by others. We conducted the present study to
assess the influence of preoperative seton drainage on the
outcome of TAFR in a relatively large series.
Methods Between December 1992 and June 2008, a
consecutive series of 278 patients [M/F=179:99, median
age 46 years (range, 19–73 years)] with cryptoglandular,
transsphincteric fistula, passing through the upper or middle
third of the external anal sphincter underwent TAFR. Patients
were recruited from the colorectal units of two university
hospitals (Erasmus Medical Center, Rotterdam, n=211; and
Leiden University Medical Center, Leiden, n=67). Baseline
characteristics did not differ between the two clinics. Sixty-
eight of these patients underwent preoperative seton drainage
for at least 2 months and until the day of the flap repair.
Results Median healing time was 2.2 months. In patients
without preoperative seton drainage, the healing rate was
63%, whereas the healing rate was 67% in patients who
underwent preoperative seton drainage. This difference was
not statistically significant. No differences in healing rates
were found between the series from Leiden and Rotterdam.
Conclusion Preoperative seton drainage does not improve
the outcome of TAFR.
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Introduction
The principle goal in the treatment of transsphincteric
fistulas passing through the upper or middle third of the
external anal sphincter is healing of the fistula, at the same
time preventing damage to the external anal sphincter.
Although transanal advancement flap repair (TAFR) pro-
vides a useful tool in achieving this goal, it has become
clear that this procedure fails in one out of three patients
[1–7]. Until now, no predictive factor for failure has been
identified. Recently, we examined the outcome of repeat
flap repair in 26 patients, who encountered a failure after
the initial procedure [8]. In all these patients, we noticed
complete healing of the advancement flap, except at the site
of the original internal opening. This remarkable clinical
finding and the lack of predictive factors for failure suggest
that persistence of the fistula might be due to ongoing
disease within the remaining fistulous tract. This theory
raises the question whether the detrimental effect of this
ongoing disease can be diminished by preoperative seton
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drainage is beneficial, since it allows drainage of the
fistulous tract, thereby reducing the inflammatory activity
within the tract and resolving secondary tracts [5, 9, 10].
Although two reports [3, 5] indicate that preoperative seton
drainage improves the healing after TAFR, this beneficial
effect could not be confirmed by others [6, 11]. However,
the reported series were rather small, and study populations
were often of heterogeneous consistency, including patients
with a rectovaginal fistula and patients with fistulas due to
Crohn's disease. The aim of the present study was to assess
the effect of preoperative seton drainage on the outcome of
TAFR in a relatively large series of patients with a high
transsphincteric fistula of cryptoglandular origin.
Patients and methods
Between December 1992 and June 2008, a consecutive
series of 278 patients with a cryptoglandular, transsphinc-
teric fistula, passing through the upper or middle third of
the external anal sphincter underwent TAFR. The patients
were recruited from the colorectal units of two university
hospitals (Erasmus Medical Center, Rotterdam, n=211 and
Leiden University Medical Center, Leiden, n=67). Baseline
patient characteristics did not differ between the two clinics.
Sixty-eight of these patients underwent preoperative seton
drainage for at least 2 months until the day of flap repair. In
the Leiden University Medical Center and in the Erasmus
Medical Center, TAFR after preoperative seton drainage
was performed in 33 and 35 patients, respectively. Clinical
charts were studied to analyze the reason for seton
placement.
Exclusion criteria
Patients with a rectovaginal fistula or a fistula due to
Crohn's disease were excluded from the present series.
Imaging
Prior to flap repair, all patients underwent either hydrogen
peroxide-enhanced endoanal ultrasonography or endoanal
magnetic resonance imaging in order to assess course of the
transsphincteric fistulous tract. These imaging techniques
were also performed to identify the location of the internal
opening and to detect the presence of any horseshoe
extensions and associated abscesses.
Surgical technique
Patients referred to the Erasmus Medical Center underwent
complete mechanical bowel preparation (polyethylene gly-
col). In the Leiden University Medical Center a single
phosphate enema was instilled on the day of the operation.
After induction of general endotracheal anesthesia, metroni-
dazole (500 mg) together with cefuroxime (1500 mg) was
administered intravenously. With the patient in prone jack-
knife position, the seton, if present, was removed. The
external opening was enlarged, and the fistulous tract was
excised through this opening until the border of the external
anal sphincter. The internal opening of the fistula was
exposed using a Lone star retractor (Lone star Retractor
System, Lone Star Medical Products®, Inc. Houston, TX).
The crypt-bearing tissue around the internal opening as well
as the overlying anodermis was then excised.The fistulous
tract was cored out of the sphincters. The defect in the
internal anal sphincter was closed with absorbable sutures. A
flap consisting of mucosa, submucosa, and some of the most
superficial fibers of the internal anal sphincter was raised
from the level of the dentate line and mobilized over a
distance of 4 to 6 cm proximally. The flap was advanced and
sutured to the neodentate line with absorbable sutures.
Postoperative care
Patients who underwent TAFR at the Erasmus Medical
Center in Rotterdam were immobilized for 5 days. Patients
received a clear liquid diet for 5 days. During this time
period, metronidazole and cefuroxime were administered
intravenously three times daily. The patients who under-
went TAFR at the Leiden University Medical Center were
immobilized for a minimum of 24 h and did not receive
additional antibiotics.
Follow-up
All patients visited the outpatient clinic at 6 and 18 weeks
and 12 months, postoperatively. Healing of the fistula was
defined as complete wound healing and closure of all
external openings in combination with absence of symptoms.
Results
The charts of 278 consecutive patients who had undergone
TAFR for cryptoglandular, transsphincteric fistulas, passing
through the upper or middle third of the external anal
sphincter were analyzed. Median healing time was
2.2 months. The present series comprised 179 men and 99
women. Median age at the time of repair was 46 years
(range, 19–73years). In patients without preoperative seton
drainage, the healing rate was 63%, whereas the healing
rate was 67% in patients who underwent preoperative seton
drainage. This difference was not statistically significant
(p=0.40). Baseline fistula and patient characteristics did not
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seton drainage (Table 1). No differences in healing rates
were found between the series from Leiden and Rotterdam
(Table 2).
Discussion
Perianal fistulas passing through the upper or middle third
of the external anal sphincter present a challenge to many
surgeons. Despite new treatment modalities such as closure
of the fistulous tract with fibrin glue or a bioprosthetic plug,
transanal advancement flap repair still provides a useful
tool in the treatment of these fistulas. It enables healing of
the fistula without damage of the external sphincter and
consequent fecal incontinence. Initially, the reported heal-
ing rates varied between 84% and 100% [12–15]. However,
during the last decade, it has become clear that TAFR fails
in one out of three patients [1–7]. Until now, no definite
risk factor for failure has been identified. Recently, we
examined the outcome of repeat flap repair in 26 patients,
who encountered a failure after the initial procedure [8]. In
all these patients, we noticed complete healing of the
advancement flap, except at the site of the original internal
opening. This remarkable clinical finding and the lack of
predictive factors for failure suggest that persistence of the
fistula might be due to ongoing disease within the
remaining fistulous tract. Obliteration of this tract with a
surgical adhesives such as fibrin glue and Bio Glue® as an
adjunct to flap repair [7, 16–18] has not only failed to
improve the healing rate, but even had a detrimental effect
on the outcome. Some authors advocate preoperative seton
drainage, since it allows drainage of the fistulous tract,
thereby reducing the inflammatory activity within the tract
and resolving secondary tracts [5, 9, 10]. In a retrospective
study, Sonoda and co-workers were the first to observe a
beneficial effect [3]. In a relatively large series of 105
patients, 56 patients underwent preoperative seton drainage.
Comparing patients with and without preoperative seton
drainage, they found a healing rate of 73.2% and 51.2%,
respectively. This difference was statistically significant.
However, their study included a large number of patients
suffering from a rectovaginal fistula and patients with a
fistula due to Crohn's disease. Only 44 patients presented
with a fistula of cryptoglandular origin. Unfortunately, the
authors omitted to provide data regarding preoperative
seton drainage in this group of patients. Van der Hagen and
co-workers described the outcome of TAFR after preoper-
ative seton drainage in 23 patients with a fistula of
cryptoglandular origin [5]. Five of these patients also had
a diverting stoma. Although the healing rate was quite high
(78%), no comparison was made with patients undergoing
TAFR alone. Two other studies, conducted by Zimmerman
et al. and by Van Koperen and co-workers indicate that
preoperative seton drainage does not affect the outcome of
TAFR [6, 11].
The present series comprised 278 patients. Sixty-eight of
our patients underwent seton drainage prior to TAFR. Since
we were not able to show any beneficial effect of
preoperative seton drainage in this relatively large series,
it seems unlikely that this type of preoperative treatment
provides a useful tool to enhance the outcome of TAFR.
However, a drawback of the present study is its retrospec-
tive design. We have considered the possibility that the
complexity of the fistula might have been a reason to allow
preoperative seton drainage. Reviewing the clinical charts,
we found no specific reasons for seton placement. Both
centers are tertiary referral centers, and the major part of the
patients was referred from smaller hospitals. A part of these
patients were admitted to one of both centers with a seton in
situ. Many surgeons are not confident with treating high
transsphincteric fistulas, and the policy of some of these
referring surgeons is to place a seton to bide the time until
definite treatment. Moreover, we analyzed the fistula
characteristics. We found no differences in the baseline
fistula and patients characteristics between patients with
and without preoperative seton drainage. Patients admitted,
to any of the centers, with a seton did not have a more
complex fistulae. Moreover, clinical chart review revealed
Table 1 Comparison of baseline patients and fistula characteristics
between patients with and without preoperative seton drainage
Seton No seton
Internal opening Posterior 63% 70%
Anterior 29% 26%
Lateral 7% 4%
Horseshoe extension Yes 50% 47%
No 50% 53%
Prior attempts at repair Yes 59% 56%
No 41% 44%
Gender Ratio (M/F) 2:1 2:1
Age (range) 43 (21–69) 46 (19–73)
Body mass index 24 25
Smoking Yes 56% 52%
No 44% 48%
Table 2 Healing rates in patients with and without preoperative seton
drainage
Leiden Rotterdam Both centers
Seton drainage 64% 69% 67%
No seton drainage 68% 62% 63%
Overall 66% 63% 64%
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was the fact that most surgeons are uncomfortable in
treating patients with a high transsphincteric fistula. To
bide the time until definite surgery, some referring
surgeons have the policy to place a seton in order to
minimize complaints and prevent acute anal sepsis.
Taking into account the facts stated above, in our
opinion, the risk on selection bias is negligible. In our
opinion, preoperative seton drainage does not positively
affect the outcome of TAFR by diminishing the
inflammatory activity in the fistulous tract.
All our patients who underwent TAFR at the Erasmus
Medical Center, in Rotterdam, were immobilized for 5 days
and received a clear liquid diet for 5 days. During this time
period, metronidazole and cefuroxime were administered
intravenously three times daily. The patients who underwent
TAFR at the Leiden University Medical Center were
immobilized for a minimum of 24 h and did not receive
additional antibiotics. Until now, there is no evidence for the
use of antibiotics, liquid diets, mechanical bowel preparation,
or for keeping patients immobilized. The lack of differences
in healing rates found between the two clinics might indicate
that these precautions have no beneficial effect. Further
research is warranted to elucidate this subject. So far, no
factors have been identified that affect the outcome of TAFR.
Persistence of the fistula seems to be caused by ongoing
disease in the remaining fistulous tract. Further research is
warranted to assess the impact of this ongoing disease on the
outcome of flap repair.
Conclusion
Seton drainage prior to TAFR does not improve the
outcome.
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